Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
128.90
+0.36 (0.28%)
Nov 28, 2025, 1:00 PM EST - Market closed
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices | 20.76B | 20.06B | 19.43B | 18.99B | 18.38B | 17.88B | 17.44B | 16.89B | ||||||||||||||||
| Medical Devices Growth | 12.99% | 12.22% | 11.40% | 12.43% | 13.48% | 14.90% | 16.10% | 14.98% | ||||||||||||||||
| Diagnostics | 9.00B | 9.16B | 9.18B | 9.34B | 9.36B | 9.39B | 9.51B | 9.99B | ||||||||||||||||
| Diagnostics Growth | -3.79% | -2.48% | -3.50% | -6.48% | -13.05% | -21.61% | -31.97% | -39.77% | ||||||||||||||||
| Nutrition | 8.64B | 8.55B | 8.49B | 8.41B | 8.32B | 8.33B | 8.26B | 8.15B | ||||||||||||||||
| Nutrition Growth | 3.82% | 2.69% | 2.86% | 3.18% | 4.90% | 8.80% | 9.60% | 9.32% | ||||||||||||||||
| Established Pharmaceuticals | 5.42B | 5.32B | 5.23B | 5.19B | 5.15B | 5.11B | 5.10B | 5.07B | ||||||||||||||||
| Established Pharmaceuticals Growth | 5.32% | 4.05% | 2.45% | 2.53% | 1.74% | 1.83% | 3.01% | 3.14% | ||||||||||||||||
| Other | 17.00M | 17.00M | 16.00M | 16.00M | 15.00M | 15.00M | 14.00M | 14.00M | ||||||||||||||||
| Other Growth | 13.33% | 13.33% | 14.29% | 14.29% | 15.38% | 25.00% | 27.27% | 27.27% |
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | 26.76B | 26.12B | 25.70B | 25.63B | 25.29B | 25.18B | 24.96B | 24.66B | ||||||||||||||||
| International Growth | 5.83% | 3.75% | 2.98% | 3.93% | 4.33% | 3.93% | 2.40% | -3.35% | ||||||||||||||||
| United States | 17.08B | 16.99B | 16.65B | 16.32B | 15.93B | 15.55B | 15.37B | 15.45B | ||||||||||||||||
| United States Growth | 7.24% | 9.27% | 8.30% | 5.64% | 1.33% | -2.83% | -10.29% | -14.83% |
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 12.11B | 11.95B | 11.80B | 11.70B | 11.51B | 11.34B | 11.15B | 10.95B | ||||||||||||||||
| Selling, General, and Administrative Growth | 5.18% | 5.40% | 5.86% | 6.83% | 2.82% | 1.21% | -0.69% | -2.66% | ||||||||||||||||
| Research and Development | 2.96B | 2.90B | 2.88B | 2.84B | 2.80B | 2.75B | 2.77B | 2.74B | ||||||||||||||||
| Research and Development Growth | 5.76% | 5.41% | 3.79% | 3.76% | 1.05% | -4.24% | -2.60% | -5.09% | ||||||||||||||||
| Amortization | 1.73B | 1.78B | 1.83B | 1.88B | 1.89B | 1.92B | 1.95B | 1.97B | ||||||||||||||||
| Amortization Growth | -8.92% | -7.55% | -6.21% | -4.48% | -4.39% | -3.18% | -2.26% | -2.33% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.